Amid Johnson & Johnson's legal battles the worst case is already priced into the stock and it's now a buy, according to Bernstein.
Bernstein upgrades J&J, says valuation is 'historically cheap'
More in Pro
- Bank of America cuts S&P 500 target to lowest on Wall Street, sees worst post-war recession in history
- Goldman says the market will turn lower again and won't bottom until these 3 things happen
- Watch the full interview with Jim Chanos on the sell-off, his biggest short and other stock traps
- Goldman found the rare companies this year that could actually grow sales and earnings
- Here are high quality stocks with 'secure' dividends for these tough times
- Subscribe to CNBC PRO
- Licensing & Reprints
- CNBC Councils
- Supply Chain Values
- Advertise With Us
- Join the CNBC Panel
- Digital Products
- News Releases
- Closed Captioning
- Corrections
- About CNBC
- Internships
- Site Map
- Podcasts
- AdChoices
- Careers
- Help
- Contact
© 2020 CNBC LLC. All Rights Reserved. A Division of NBCUniversal
Data is a real-time snapshot *Data is delayed at least 15 minutes. Global Business and Financial News, Stock Quotes, and Market Data and Analysis.
Data also provided by 